July 7 (Reuters) - ResMed said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier ...

Selling the software business to Frazier Healthcare Partners will allow the respiratory device maker to shift more resources ...

Frazier Healthcare Partners ("Frazier"), a private equity firm focused exclusively on the healthcare industry, today ...

Frazier Healthcare Partners announced on Tuesday it has entered into a definitive agreement to acquire MatrixCare from Resmed (RMD). The company said MatrixCare provides cloud-based EHR software ...

ResMed is selling its MatrixCare home-health software unit to Frazier Healthcare Partners for $490m in cash to focus on sleep and breathing care.

ResMed Inc (ASX: RMD) announces sale of MatrixCare for $490m, plans capital return, and reaffirms FY26 guidance.

Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has entered into a definitive agreement to sell its ...

Resmed said it would sell its MatrixCare business to Frazier Healthcare Partners, a health-care focused private equity firm, for $490 million. Resmed, a global medical equipment company, said it ...

Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.

Resmed has entered a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused on health care ...

The medical device maker has sold the MatrixCare business for less than it bought it eight years ago, with analysts pointing ...